Suresh Kalathil
- Immunology top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Hepatology top 5%
- Co-authors
- Yasmin ThanavalaAustin MillerAmit A. LugadeRenuka IyerTariq A. BhatAlan D. HutsonVandana PradhanSanjay Sethi
- Topics
- Cancer Immunotherapy and Biomarkers (7 papers)Immune Cell Function and Interaction (7 papers)Immunotherapy and Immune Responses (5 papers)
- Cited by
- ImmunologyHepatologyOncology
- Journals
- The Journal of ImmunologyAmerican Journal of Respiratory and Critical Care MedicineCancer Research
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Suresh Kalathil
25 papers receiving 925 citations
Peers
Comparison fields: 5 of 94
- Immunology 431
- Oncology 344
- Pulmonary and Respiratory Medicine 248
- Molecular Biology 163
- Hepatology 128
Countries citing papers authored by Suresh Kalathil
This map shows the geographic impact of Suresh Kalathil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Kalathil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Kalathil more than expected).
Fields of papers citing papers by Suresh Kalathil
This network shows the impact of papers produced by Suresh Kalathil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Kalathil. The network helps show where Suresh Kalathil may publish in the future.
Co-authorship network of co-authors of Suresh Kalathil
This figure shows the co-authorship network connecting the top 25 collaborators of Suresh Kalathil. A scholar is included among the top collaborators of Suresh Kalathil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh Kalathil. Suresh Kalathil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 17 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 38 | |
| 6 | 23 | |
| 7 | 13 | |
| 8 | 54 | |
| 9 | 44 | |
| 10 | 57 | |
| 11 | 60 | |
| 12 | 8 | |
| 13 | 157 | |
| 14 | 103 | |
| 15 | 232 | |
| 16 | 3 | |
| 17 | 15 | |
| 18 | 2 | |
| 19 | 18 | |
| 20 | 11 |
About Suresh Kalathil
Suresh Kalathil is a scholar working on Immunology, Emergency Medical Services and Oncology, having authored 25 papers that have together received 937 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Immunology (431 citations), Hepatology (128 citations) and Oncology (344 citations). Suresh Kalathil has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Yasmin Thanavala, Austin Miller, Amit A. Lugade, Renuka Iyer, Tariq A. Bhat, Alan D. Hutson, Vandana Pradhan, Sanjay Sethi, Ganapathi I. Parameswaran and Joseph Barbi. Their work appears in journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.